BM , RC they know what we can only speculate based on what we're told " dangling the carrot" or read in the press . Teva pipeline of products resulting in endless write downs , generic Nuvaring still waiting for FDA approval , E4 trying to get off the ground by means of a hugely expensive marketing program on top of paying through the nose for an unproven product that may or may not prove successful , time will tell . With the Supreme Court of Victoria MYX class action and US States suing a number of Pharma companies including us why would BM and RC continue to hold whats become a speculative stock at their time in life huge holdings on whats still a relatively med / long term stock before maybe anything like approaching a dollar , relying mainly on one product E4 becoming successful . E4 seems a better product than most competitors but definitely not without its share of limitations . Hopefully we see a bit more buying and less selling soon .
MYX Price at posting:
32.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)